全文获取类型
收费全文 | 1970篇 |
免费 | 117篇 |
国内免费 | 38篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 63篇 |
妇产科学 | 35篇 |
基础医学 | 239篇 |
口腔科学 | 62篇 |
临床医学 | 164篇 |
内科学 | 363篇 |
皮肤病学 | 40篇 |
神经病学 | 77篇 |
特种医学 | 191篇 |
外科学 | 216篇 |
综合类 | 179篇 |
一般理论 | 2篇 |
预防医学 | 194篇 |
眼科学 | 43篇 |
药学 | 138篇 |
1篇 | |
中国医学 | 15篇 |
肿瘤学 | 96篇 |
出版年
2023年 | 36篇 |
2022年 | 76篇 |
2021年 | 116篇 |
2020年 | 63篇 |
2019年 | 56篇 |
2018年 | 87篇 |
2017年 | 52篇 |
2016年 | 54篇 |
2015年 | 59篇 |
2014年 | 64篇 |
2013年 | 90篇 |
2012年 | 121篇 |
2011年 | 136篇 |
2010年 | 88篇 |
2009年 | 84篇 |
2008年 | 83篇 |
2007年 | 101篇 |
2006年 | 67篇 |
2005年 | 55篇 |
2004年 | 56篇 |
2003年 | 39篇 |
2002年 | 40篇 |
2001年 | 16篇 |
2000年 | 19篇 |
1999年 | 22篇 |
1998年 | 46篇 |
1997年 | 38篇 |
1996年 | 43篇 |
1995年 | 28篇 |
1994年 | 22篇 |
1993年 | 25篇 |
1992年 | 13篇 |
1991年 | 8篇 |
1990年 | 9篇 |
1989年 | 25篇 |
1988年 | 24篇 |
1987年 | 19篇 |
1986年 | 24篇 |
1985年 | 21篇 |
1984年 | 6篇 |
1983年 | 5篇 |
1982年 | 18篇 |
1981年 | 9篇 |
1980年 | 13篇 |
1979年 | 3篇 |
1978年 | 6篇 |
1977年 | 9篇 |
1976年 | 9篇 |
1975年 | 7篇 |
1953年 | 2篇 |
排序方式: 共有2125条查询结果,搜索用时 15 毫秒
41.
42.
Noor H. A. Suaini Yuxia Zhang Peter J. Vuillermin Katrina J. Allen Leonard C. Harrison 《Nutrients》2015,7(8):6088-6108
Apart from its classical function in bone and calcium metabolism, vitamin D is also involved in immune regulation and has been linked to various cancers, immune disorders and allergic diseases. Within the innate and adaptive immune systems, the vitamin D receptor and enzymes in monocytes, dendritic cells, epithelial cells, T lymphocytes and B lymphocytes mediate the immune modulatory actions of vitamin D. Vitamin D insufficiency/deficiency early in life has been identified as one of the risk factors for food allergy. Several studies have observed an association between increasing latitude and food allergy prevalence, plausibly linked to lower ultraviolet radiation (UVR) exposure and vitamin D synthesis in the skin. Along with mounting epidemiological evidence of a link between vitamin D status and food allergy, mice and human studies have shed light on the modulatory properties of vitamin D on the innate and adaptive immune systems. This review will summarize the literature on the metabolism and immune modulatory properties of vitamin D, with particular reference to food allergy. 相似文献
43.
Zahida Sarwar Andrea Cutherell Arif Noor Farah Naureen Jennifer Norman 《Health research policy and systems / BioMed Central》2015,13(Z1):S50
While Pakistan has made progress toward achieving Millennium Development Goal 5 for maternal health, it is unlikely to achieve the target; further, it is also not on track for Millennium Development Goal 4 regarding child health. Two low-cost, temperature stable and life-saving drugs, misoprostol and chlorhexidine, can respectively avert maternal and newborn deaths, and are particularly pertinent for poor and marginalized areas which bear the brunt of maternal and newborn deaths in Pakistan. In response, Mercy Corps led focused advocacy efforts to promote changes in policies, protocols, and regulatory environments for misoprostol (2012–2014) and for chlorhexidine (2014). These short-duration advocacy projects facilitated significant policy gains, such as inclusion of misoprostol and chlorhexidine into province-specific essential drug lists, development and endorsement of clinical protocols for the two drugs by provincial health departments, inclusion of misoprostol into pre-service training curriculum for several health cadres, and application for registration of chlorhexidine (at the concentration required for newborn care) by two pharmaceutical companies. These results were achieved by a consultative and evidence-based process which generated feedback from community members, program implementers, and policymakers, and ultimately put the government in the driver’s seat to facilitate change. Community Action Dialogue forums were linked with provincial-level Technical Working Groups and Provincial Steering Committees, who passed on endorsed recommendations to the Health Secretary. The key factors which facilitated change were the identification of champions within the provincial health departments, prioritization of relationship building and follow-up, focus on concrete advocacy aims rather than broad objectives, and the use of multi-stakeholder forums to secure an enabling environment for the policy changes to take root. While these advocacy initiatives resulted in significant policy changes in Pakistan’s devolved health system, to ensure these policy changes have an impact on health outcomes, Pakistan should focus on the scale-up of appropriate use of chlorhexidine and misoprostol. Further, future policy initiatives in Pakistan should make use of similar multi-stakeholder policy forums, while ensuring a third party to facilitate the process so that civil society and community voices are not lost in the policy development discussion. 相似文献
44.
Hassan Waleed A. Medhat Basma M. Youssef Maha M. Farag Yomna Mostafa Noha Alnaggar Alshaimaa R. Behiry Mervat E. Abdel Noor Rasha A. Allam Riham S. H. M 《Clinical rheumatology》2021,40(4):1599-1610
Clinical Rheumatology - To investigate the characteristics, evolution, and visual outcome of non-infectious uveitis. Records of 201 patients with non-infectious uveitis (136 (67.7%) males and 84... 相似文献
45.
Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model 总被引:1,自引:0,他引:1
Lin R Peng H Nguyen LP Dudekula NB Shardonofsky F Knoll BJ Parra S Bond RA 《Pulmonary pharmacology & therapeutics》2008,21(1):115-124
BACKGROUND: We have previously reported that chronic treatment with certain 'beta-blockers' reduces airway hyperresponsiveness (AHR) to methacholine in a murine model of asthma. METHODS: Airway resistance was measured using the forced oscillation technique in ovalbulmin-sensitized and ovalbulmin-challenged mice treated with several beta-adrenoceptor (beta-AR) ligands. We used the selective beta 2-AR ligand ICI 118,551 and the preferential beta 1-AR ligand metoprolol to investigate the receptor subtype mediating the beneficial effect. Expression of beta-ARs was evaluated using immunofluorescence. We evaluated several signaling proteins by western blot using lung homogenates, and measured the relaxation of the isolated trachea produced by EP2 and IP receptor agonists. RESULTS: Four findings were associated with the decreased AHR after chronic beta-blocker treatment: (1) the highly selective beta 2-AR antagonist/inverse agonist, ICI 118,551 produced the bronchoprotective effect; (2) beta 2-AR up-regulation resulted from chronic 'beta-blocker' treatment; (3) reduced expression of certain proteins involved in regulating bronchial tone, namely, Gi, phosphodiesterase 4D and phospholipase C-beta 1; and (4) an enhanced bronchodilatory response to prostanoid agonists for the IP and EP2 receptors. CONCLUSIONS: These data suggest that in the murine model of asthma, several compensatory changes associated with either increased bronchodilator signaling or decreased bronchoconstrictive signaling, result from the chronic administration of certain 'beta-blockers'. 相似文献
46.
Lo JC Mulligan K Noor MA Schwarz JM Halvorsen RA Grunfeld C Schambelan M 《The Journal of clinical endocrinology and metabolism》2001,86(8):3480-3487
GH has been proposed as a therapy for patients with HIV-associated fat accumulation, but the pharmacological doses (6 mg/d) used have been associated with impaired fasting glucose and hyperglycemia. In contrast, physiologic doses of GH ( approximately 1 mg/d) in HIV-negative men reduced visceral adiposity and eventually improved insulin sensitivity, despite initially causing insulin resistance. We conducted an open-label study to evaluate the effects of a lower pharmacologic dose of GH (3 mg/d) in eight men with HIV-associated fat accumulation. Oral glucose tolerance, insulin sensitivity, and body composition were measured at baseline, and 1 and 6 months. Six patients completed 1 month and 5, 6 months of GH therapy. IGF-I levels increased 4-fold within 1 month of GH treatment. Over 6 months, GH reduced buffalo hump size and excess visceral adipose tissue. Total body fat decreased (17.9 +/- 10.9 to 13.5 +/- 8.4 kg, P = 0.05), primarily in the trunk region. Lean body mass increased (62.9 +/- 6.4 to 68.3 +/- 9.1 kg, P = 0.03). Insulin-mediated glucose disposal, measured by a euglycemic hyperinsulinemic clamp, declined at month 1 (49.7 +/- 27.5 to 25.6 +/- 6.6 nmol/kg(LBM).min/pmol(INSULIN)/liter, P = 0.04); values improved at month 6 (49.2 +/- 22.6, P = 0.03, compared with month 1) and did not differ significantly from baseline. Similarly, the integrated response to an oral glucose load worsened at month 1 (glucose area under the curve 20.1 +/- 2.3 to 24.6 +/- 3.7 mmol.h/liter, P < 0.01), whereas values improved at month 6 (22.1 +/- 1.5, P = 0.02, compared with month 1) and did not differ significantly from baseline. One patient developed symptomatic hyperglycemia within 2 wk of GH initiation; baseline oral glucose tolerance testing revealed preexisting diabetes despite normal fasting glucose. In conclusion, GH at 3 mg/d resulted in a decrease in total body fat and an increase in lean body mass in this open-label trial. While insulin sensitivity and glucose tolerance initially worsened, they subsequently improved toward baseline. However, the dose of GH used in this trial was supraphysiologic and led to an increase in IGF-I levels up to three times the upper normal range. Because there are known adverse effects of long-term GH excess, the effectiveness of lower doses of GH should be studied. We also recommend a screening oral glucose tolerance test be performed to exclude subjects at risk for GH-induced hyperglycemia. 相似文献
47.
48.
Noor H. A. Suaini Evelyn Xiu-Ling Loo Rachel L. Peters Gaik Chin Yap Katrina J. Allen Hugo Van Bever David J. Martino Anne Eng Neo Goh Shyamali C. Dharmage Marjorelee T. Colega Mary Foong Fong Chong Anne-Louise Ponsonby Kok Hian Tan Mimi L. K. Tang Keith M. Godfrey Bee Wah Lee Lynette Pei-Chi Shek Jennifer J. Koplin Elizabeth Huiwen Tham 《Allergy》2021,76(10):3171-3182
49.
Noor Fatima Majeed Marta Braschi Amirfarzan Christoph Wald Jeremy R Wortman 《The British journal of radiology》2021,94(1123)
Objective:Spectral detector CT (SDCT) has many applications in advanced liver imaging. If appropriately utilized, this technology has the potential to improve image quality, provide new diagnostic information, and allow for decreased radiation dose. The purpose of this review is to familiarize radiologists with the uses of SDCT in liver imaging.Conclusion:SDCT has a variety of post-processing techniques, which can be used in advanced liver imaging and can significantly add value in clinical practice. 相似文献
50.